A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells

E-ISSN： 1860-7187|13|1|25-29

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.13, Iss.1, 2018-01, pp. : 25-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthesis and Immunological Evaluation of a Multicomponent Cancer Vaccine Candidate Containing a Long MUC1 Glycopeptide

CHEMBIOCHEM, Vol. 19, Iss. 2, 2018-01 ,pp. : 121-125

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Delivery of Vaccine to Dendritic Cells by Chitosan Nanoparticles Conjugated with a Targeting Peptide Ligand Selected by Phage Display Technique

MACROMOLECULAR BIOSCIENCE (ELECTRONIC), Vol. 15, Iss. 3, 2015-03 ,pp. : 395-404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T‐Cell Epitopes from Tetanus Toxoid

ANGEWANDTE CHEMIE INTERNATIONAL EDITION, Vol. 52, Iss. 23, 2013-06 ,pp. : 6106-6110

John Wiley & Sons Inc

Access to resources Recommend Favorite

JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol. 67, Iss. 9, 2015-09 ,pp. : 1215-1231

John Wiley & Sons Inc

Access to resources Recommend Favorite

Horizons in Chemical Immunology - Approaches to Synthetic Vaccine Design

By Robinson John A.

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 3, 2007-03 ,pp. : 84-92

Swiss Chemical Society

Access to resources Recommend Favorite